Paradigm Biocapital Advisors LP

Holdings History for Lexeo Therapeutics, Inc. - Common Stock ($0.0001 par value) (the "Shares") (LXEO)

Symbol: LXEO on Nasdaq
Investment type: Equity / Common Stock ($0.0001 par value) (the "Shares")
Latest Disclosed Shares Owned: 4,763,198 shares
Security Ownership %: 6.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)

17 Feb 2026 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,763,198 shares of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO). This represents 6.5% ownership of the company. In their previous filing dated 20 Nov 2025, Paradigm Biocapital Advisors LP had reported owning 3,671,999 shares, indicating an increase of +30%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	6.5%	+30%	$35,390,561	4,763,198	+1,091,199	+30%	$7.43	13G/A	31 Dec 2025	17 Feb 2026, 16:02
Paradigm BioCapital Advisors LP	5%		$33,047,991	3,671,999			$9.00	13G	13 Nov 2025	20 Nov 2025, 16:30

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		1.3%	+1.3%	$47,298,556	4,763,198	+4,763,198	NEW	$9.93	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.